GlassScriptPhysician profile
Arash A Dini
NPI 1841433547
$1,177.04
in general payments reported to CMS, 2019-2025
10 companies · $132 in 2025
The $132 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $639 · 2020: $52.00 · 2021: $129 · 2022: $65.84 · 2023: $80.60 · 2024: $78.02 · 2025: $132.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $291.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $291.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linvatec Corporation | $537.28 | 2019-2025 | Biobrace 23mm, Linvatec Arthroscopy |
| Smith+Nephew, INC. | $274.70 | 2019-2025 | Grafix Pl |
| Anika Therapeutics, INC. | $135.95 | 2019 | |
| Boston Scientific Corporation | $57.00 | 2024-2025 | General - Pain Management |
| Bioventus LLC | $54.59 | 2022-2025 | Exogen Ultrasound Bone Healing System |
| Encore Medical, LP | $29.12 | 2025 | Djo Surgical |
| Globus Medical, INC. | $26.10 | 2023 | Allocate |
| Depuy Synthes Sales INC. | $23.80 | 2024 | Orthovisc |
| Stryker Corporation | $22.68 | 2022 | |
| Djo, LLC | $15.82 | 2025 | Donjoy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arash Dini listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.